annual SGA:
$0.00-$108.15M(-100.00%)Summary
- As of today (September 17, 2025), MDGL annual SGA is $0.00, with the most recent change of -$108.15 million (-100.00%) on December 31, 2024.
- During the last 3 years, MDGL annual SGA has fallen by -$37.32 million (-100.00%).
- MDGL annual SGA is now -100.00% below its all-time high of $108.15 million, reached on December 31, 2023.
Performance
MDGL SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$167.88M(-100.00%)Summary
- As of today (September 17, 2025), MDGL quarterly SGA is $0.00, with the most recent change of -$167.88 million (-100.00%) on June 30, 2025.
- Over the past year, MDGL quarterly SGA has dropped by -$105.45 million (-100.00%).
- MDGL quarterly SGA is now -100.00% below its all-time high of $167.88 million, reached on March 31, 2025.
Performance
MDGL quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$7.34B-$281.90M(-4.00%)Summary
- As of today (September 17, 2025), MDGL TTM SGA is -$7.34 billion, with the most recent change of -$281.90 million (-4.00%) on June 30, 2025.
- Over the past year, MDGL TTM SGA has dropped by -$7.60 billion (-2918.36%).
- MDGL TTM SGA is now -5620.26% below its all-time high of -$128.28 million.
Performance
MDGL TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MDGL Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -100.0% | -2918.4% |
| 3 y3 years | -100.0% | -100.0% | -10000.0% |
| 5 y5 years | -100.0% | -100.0% | -10000.0% |
MDGL Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low | -163.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low | -643.9% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low | -5620.3% | at low |
MDGL Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $275.46M(-27.7%) |
| Mar 2025 | - | $167.88M(>+9900.0%) | $380.91M(+29.6%) |
| Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $293.83M(-13.7%) |
| Sep 2024 | - | $107.58M(+2.0%) | $340.37M(+30.7%) |
| Jun 2024 | - | $105.45M(+30.5%) | $260.37M(+50.7%) |
| Mar 2024 | - | $80.80M(+73.6%) | $172.76M(+59.8%) |
| Dec 2023 | $108.15M(+124.7%) | $46.54M(+68.7%) | $108.15M(+42.0%) |
| Sep 2023 | - | $27.58M(+54.6%) | $76.17M(+25.4%) |
| Jun 2023 | - | $17.84M(+10.3%) | $60.73M(+11.1%) |
| Mar 2023 | - | $16.18M(+11.2%) | $54.65M(+13.6%) |
| Dec 2022 | $48.13M(+29.0%) | $14.56M(+19.9%) | $48.13M(+6.3%) |
| Sep 2022 | - | $12.14M(+3.1%) | $45.28M(+9.3%) |
| Jun 2022 | - | $11.77M(+21.9%) | $41.43M(+4.2%) |
| Mar 2022 | - | $9.66M(-17.5%) | $39.77M(+6.6%) |
| Dec 2021 | $37.32M(+70.7%) | $11.71M(+41.3%) | $37.32M(+17.6%) |
| Sep 2021 | - | $8.29M(-18.0%) | $31.73M(+9.7%) |
| Jun 2021 | - | $10.11M(+40.2%) | $28.94M(+18.3%) |
| Mar 2021 | - | $7.21M(+17.7%) | $24.47M(+11.9%) |
| Dec 2020 | $21.86M(-3.5%) | $6.13M(+11.5%) | $21.86M(+5.2%) |
| Sep 2020 | - | $5.49M(-2.6%) | $20.78M(+3.7%) |
| Jun 2020 | - | $5.64M(+22.5%) | $20.04M(-6.8%) |
| Mar 2020 | - | $4.61M(-8.7%) | $21.51M(-5.0%) |
| Dec 2019 | $22.65M(+48.1%) | $5.04M(+6.2%) | $22.65M(-2.3%) |
| Sep 2019 | - | $4.75M(-33.2%) | $23.19M(-1.6%) |
| Jun 2019 | - | $7.11M(+23.7%) | $23.56M(+22.9%) |
| Mar 2019 | - | $5.75M(+2.9%) | $19.17M(+25.3%) |
| Dec 2018 | $15.29M(+99.3%) | $5.58M(+9.0%) | $15.29M(+26.3%) |
| Sep 2018 | - | $5.12M(+88.5%) | $12.11M(+35.4%) |
| Jun 2018 | - | $2.72M(+45.2%) | $8.94M(+13.9%) |
| Mar 2018 | - | $1.87M(-22.0%) | $7.85M(+2.3%) |
| Dec 2017 | $7.67M(-17.4%) | $2.40M(+22.7%) | $7.67M(+2.2%) |
| Sep 2017 | - | $1.96M(+20.5%) | $7.50M(-36.6%) |
| Jun 2017 | - | $1.62M(-4.2%) | $11.84M(+10.0%) |
| Mar 2017 | - | $1.70M(-24.1%) | $10.76M(+15.9%) |
| Dec 2016 | $9.29M(+1052.9%) | $2.23M(-64.5%) | $9.29M(+29.0%) |
| Sep 2016 | - | $6.29M(+1040.8%) | $7.20M(+545.8%) |
| Jun 2016 | - | $551.00K(+148.2%) | $1.12M(-69.8%) |
| Mar 2016 | - | $222.00K(+53.0%) | $3.69M(-51.6%) |
| Dec 2015 | $805.80K(-94.9%) | $145.10K(-26.5%) | $7.62M(-35.0%) |
| Sep 2015 | - | $197.40K(-93.7%) | $11.72M(-20.6%) |
| Jun 2015 | - | $3.13M(-24.7%) | $14.76M(+1.3%) |
| Mar 2015 | - | $4.15M(-2.1%) | $14.57M(-7.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | $15.75M(+0.3%) | $4.24M(+30.9%) | $15.75M(+5.2%) |
| Sep 2014 | - | $3.24M(+10.2%) | $14.97M(-5.8%) |
| Jun 2014 | - | $2.94M(-44.8%) | $15.90M(-7.3%) |
| Mar 2014 | - | $5.32M(+53.7%) | $17.14M(+9.2%) |
| Dec 2013 | $15.70M(+34.5%) | $3.46M(-17.0%) | $15.70M(+0.7%) |
| Sep 2013 | - | $4.17M(-0.4%) | $15.59M(+9.7%) |
| Jun 2013 | - | $4.19M(+8.0%) | $14.21M(+10.1%) |
| Mar 2013 | - | $3.88M(+15.7%) | $12.91M(+10.6%) |
| Dec 2012 | $11.68M(+1.1%) | $3.35M(+19.9%) | $11.68M(+4.9%) |
| Sep 2012 | - | $2.80M(-3.0%) | $11.13M(-2.9%) |
| Jun 2012 | - | $2.88M(+8.9%) | $11.46M(-0.6%) |
| Mar 2012 | - | $2.65M(-5.6%) | $11.53M(-0.2%) |
| Dec 2011 | $11.55M(+0.9%) | $2.80M(-10.5%) | $11.55M(+1.9%) |
| Sep 2011 | - | $3.13M(+6.3%) | $11.34M(+5.0%) |
| Jun 2011 | - | $2.95M(+10.2%) | $10.80M(+2.2%) |
| Mar 2011 | - | $2.67M(+3.1%) | $10.57M(-3.8%) |
| Dec 2010 | $11.45M(-9.5%) | $2.59M(+0.0%) | $10.98M(+1.5%) |
| Sep 2010 | - | $2.59M(-4.6%) | $10.82M(-4.9%) |
| Jun 2010 | - | $2.72M(-12.0%) | $11.38M(-2.5%) |
| Mar 2010 | - | $3.09M(+27.2%) | $11.67M(-7.8%) |
| Dec 2009 | $12.65M(-14.2%) | $2.43M(-23.0%) | $12.65M(-7.6%) |
| Sep 2009 | - | $3.15M(+4.8%) | $13.69M(-3.6%) |
| Jun 2009 | - | $3.00M(-26.2%) | $14.21M(-6.4%) |
| Mar 2009 | - | $4.07M(+17.3%) | $15.18M(+3.0%) |
| Dec 2008 | $14.74M(-1.3%) | $3.47M(-5.3%) | $14.74M(-1.9%) |
| Sep 2008 | - | $3.67M(-7.8%) | $15.02M(-1.2%) |
| Jun 2008 | - | $3.97M(+9.4%) | $15.21M(+0.8%) |
| Mar 2008 | - | $3.63M(-3.2%) | $15.09M(+1.1%) |
| Dec 2007 | $14.93M(+72.7%) | $3.75M(-2.6%) | $14.93M(+9.0%) |
| Sep 2007 | - | $3.85M(-0.0%) | $13.69M(+15.5%) |
| Jun 2007 | - | $3.85M(+11.1%) | $11.86M(+19.4%) |
| Mar 2007 | - | $3.47M(+37.7%) | $9.93M(+14.8%) |
| Dec 2006 | $8.65M(-23.3%) | $2.52M(+24.9%) | $8.65M(+41.1%) |
| Sep 2006 | - | $2.02M(+4.7%) | $6.13M(+49.0%) |
| Jun 2006 | - | $1.93M(-12.1%) | $4.12M(+87.9%) |
| Mar 2006 | - | $2.19M(-3.9%) | $2.19M(-3.9%) |
| Dec 2005 | $11.28M(+52.8%) | - | - |
| Mar 2005 | - | $2.28M | $2.28M |
| Dec 2004 | $7.38M(+40.3%) | - | - |
| Dec 2003 | $5.26M(+235.3%) | - | - |
| Dec 2002 | $1.57M(+1165.3%) | - | - |
| Dec 2001 | $124.00K | - | - |
FAQ
- What is Madrigal Pharmaceuticals, Inc. annual SGA?
- What is the all time high annual SGA for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. annual SGA year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. quarterly SGA year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. TTM SGA?
- What is the all time high TTM SGA for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. TTM SGA year-on-year change?
What is Madrigal Pharmaceuticals, Inc. annual SGA?
The current annual SGA of MDGL is $0.00
What is the all time high annual SGA for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high annual SGA is $108.15M
What is Madrigal Pharmaceuticals, Inc. annual SGA year-on-year change?
Over the past year, MDGL annual SGA has changed by -$108.15M (-100.00%)
What is Madrigal Pharmaceuticals, Inc. quarterly SGA?
The current quarterly SGA of MDGL is $0.00
What is the all time high quarterly SGA for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high quarterly SGA is $167.88M
What is Madrigal Pharmaceuticals, Inc. quarterly SGA year-on-year change?
Over the past year, MDGL quarterly SGA has changed by -$105.45M (-100.00%)
What is Madrigal Pharmaceuticals, Inc. TTM SGA?
The current TTM SGA of MDGL is -$7.34B
What is the all time high TTM SGA for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high TTM SGA is -$128.28M
What is Madrigal Pharmaceuticals, Inc. TTM SGA year-on-year change?
Over the past year, MDGL TTM SGA has changed by -$7.60B (-2918.36%)